Pear Therapeutics Inc (PEAR) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access PEAR Annual Balance Sheets →
The data below summarizes Pear Therapeutics Inc's balance sheet position from Dec 31 2021 to Dec 31 2022, enabling a period-by-period comparison of financial strength.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2022)
(Sep 30 2022) (Jun 30 2022) (Mar 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent48.30
Short-term Investments, Total10.97
Cash & Short-term Investments58.00
Accounts receivable6.94
Other Current Assets0.07
Prepaid Expense And Other Assets Current6.68
Total Current Assets72.96
Equipment/Property/Plant Net6.08
Other Assets, Noncurrent16.09
Restricted Cash Current0.07
Restricted Cash Noncurrent0.41
Total Assets95.13
Liabilities
Accounts Payable, Current AC3.26
Long-term Debt, Current Maturities LO27.45
Other Liabilities, Current18.73
Total Current Liabilities49.44
Total Long-term Debt0.00
Other liabilities, Noncurrent15.10
Contract With Customer Liability Current0.28
Embedded Derivative Fair Value Of Embedded Derivative Liability1.25
Warrant Liability Noncurrent2.12
Total Liabilities64.54
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock354.09
Retained Earnings / Accumulated Deficit-323.47
Other Equity-0.05
Common Stockholder's Equity30.59
Total Stockholder's Equity30.59
Liabilities & Stockholder's Equity95.13
4 historic quarters locked

Sign in to unlock the full Pear Therapeutics Inc balance sheet history.

About Pear Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001835567-23-000018

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.